Marc Beer is one of the few global investors that have admirable careers. His expertise in solving critical health conditions through innovative strategies is something unique in his career. Besides, Beer is among the talented investors that have a history of founding successful companies. Many entrepreneurs succeed in their other businesses, but Marc made headlines after selling his first startup at a reasonable price. His ability to blend biotechnology and entrepreneurship makes him stand up as one of the reputable businesspersons.
After completing his studies in 1987, Marc Beer started his career working at Genzyme. Through the extensive training he acquired from the University of Miami, Beer’s contribution to the company’s sales department was credible. Besides, his talent contributed significantly to his ability to oversee the marketing and sales departments of the company. His hard work rewarded him by his appointment as the company’s Global Marketing Deputy President. The office became the stepping-stone of his success because of the exposure to the outside world.
During his tenure in the Global Marketing portfolio, Marc Beer made numerous trips promoting the Genzyme’s product line. The line’s primary purpose was to solve the over 7,000 rare diseases affecting more than 350 million people globally. The desire to help people more aggressively made Beer to think of better solutions. He decided to face the problem alone in the pharmaceutical industry by starting his first biotechnology company he named ViaCell.
Marc Beer used ViaCell as the bridge towards the success in finding the treatment to various health conditions. The company specialized in developing umbilical stem blood cells. The over 300 employees had the task of collecting and professionally preserving the cells. After seven years in business, Marc sold the company to PerkinElmer. The deal that earned him $300 million opened his doors to success in biotechnology.
Marc Beer had spent two years mourning his 42 years old wife that passed on after the sale of ViaCell before starting Renovia Inc. The wife succumbed to pulmonary embolism, leaving Marc with the task of taking care of their three children. He founded Renovia after his 14 years old daughter comforted him to go back to business. Beer collaborated with Dr. Ray Iglesias, a renowned gynecologist and Yolanda Lorié to start the company in 2016. The company specializes in finding solutions for solving the problem of pelvic floor disorders in women.
As the Chairman and CEO of Renovia, Marc Beer helped in raising the funds that would help the company research and develop diagnostic and therapeutic solutions of the matter. The Leva device is the latest product. Through Series B funding, Renovia raised over $42 million toward the initiative. The company’s primary aim is to remove the stigma associated with the disease. Beer’s connection with renowned Fund companies like Ascension Ventures, The Longwood Fund, and Perceptive Advisors led to the success of the Fund.
Follow Marc here: https://www.facebook.com/people/Marc-Beer/100009146215501